Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
06 2020
Historique:
received: 30 10 2019
accepted: 02 03 2020
pubmed: 18 3 2020
medline: 12 5 2021
entrez: 18 3 2020
Statut: ppublish

Résumé

Pancreatic enucleation (PE) is a viable option for the removal of non-malignant pancreatic masses leading to complete preservation of organ function. Nevertheless, PE is associated with substantial rates of post-operative pancreatic fistula (POPF), particularly when the mass is close to the main pancreatic duct (MPD). Preoperative stenting of the MPD may prevent its injury when performing PE. This paper describes a novel technique of "deep" PE preceded by endoscopic stenting of the MPD. From January 2017 to May 2019, patients with small pancreatic neuroendocrine tumors proximal to the MPD were candidates for PE with previous stenting of the MPD at the University of Verona, Italy, and at the UCLA Medical Center, Los Angeles, California. The endoscopic stenting was scheduled either the day before or 3 weeks before surgery, depending on the participating institute. Ten patients were included in this pilot study. The endoscopic procedure was successful and well tolerated in all cases. Open, laparoscopic and robotic PE were performed. Seven patients had surgical complications. Among these, six developed a post-operative pancreatic fistula (POPF), but neither grade C fistulas nor disruptions of the MPD were detected. At pathology, a low grade pancreatic neuroendocrine tumor was confirmed in all cases. In the setting of high-volume centers, this procedure is safe, and it is associated with acceptable short-term surgical morbidity. The preoperative stenting of the MPD might extend the surgical indications for PE.

Sections du résumé

BACKGROUND
Pancreatic enucleation (PE) is a viable option for the removal of non-malignant pancreatic masses leading to complete preservation of organ function. Nevertheless, PE is associated with substantial rates of post-operative pancreatic fistula (POPF), particularly when the mass is close to the main pancreatic duct (MPD). Preoperative stenting of the MPD may prevent its injury when performing PE. This paper describes a novel technique of "deep" PE preceded by endoscopic stenting of the MPD.
METHODS
From January 2017 to May 2019, patients with small pancreatic neuroendocrine tumors proximal to the MPD were candidates for PE with previous stenting of the MPD at the University of Verona, Italy, and at the UCLA Medical Center, Los Angeles, California. The endoscopic stenting was scheduled either the day before or 3 weeks before surgery, depending on the participating institute.
RESULTS
Ten patients were included in this pilot study. The endoscopic procedure was successful and well tolerated in all cases. Open, laparoscopic and robotic PE were performed. Seven patients had surgical complications. Among these, six developed a post-operative pancreatic fistula (POPF), but neither grade C fistulas nor disruptions of the MPD were detected. At pathology, a low grade pancreatic neuroendocrine tumor was confirmed in all cases.
CONCLUSION
In the setting of high-volume centers, this procedure is safe, and it is associated with acceptable short-term surgical morbidity. The preoperative stenting of the MPD might extend the surgical indications for PE.

Identifiants

pubmed: 32180000
doi: 10.1007/s00464-020-07501-y
pii: 10.1007/s00464-020-07501-y
doi:

Types de publication

Evaluation Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2796-2802

Références

Crippa S, Bassi C, Salvia R, Falconi M, Butturini G, Pederzoli P (2007) Enucleation of pancreatic neoplasms. Br J Surg. https://doi.org/10.1002/bjs.5833
doi: 10.1002/bjs.5833 pubmed: 17583892
Cauley CE, Pitt HA, Ziegler KM, Nakeeb A, Schmidt CM, Zyromski NJ, House MG, Lillemoe KD (2012) Pancreatic enucleation: improved outcomes compared to resection. J Gastrointest Surg. https://doi.org/10.1007/s11605-012-1893-7
doi: 10.1007/s11605-012-1893-7 pubmed: 22528577
Hackert T, Hinz U, Fritz S, Strobel O, Schneider L, Hartwig W, Büchler MW, Werner J (2011) Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbeck’s Arch Surg. https://doi.org/10.1007/s00423-011-0801-z
doi: 10.1007/s00423-011-0801-z
Talamini MA, Moesinger R, Yeo CJ, Poulose B, Hruban RH, Cameron JL, Pitt HA (1998) Cystadenomas of the pancreas: is enucleation an adequate operation? Ann Surg. https://doi.org/10.1097/00000658-199806000-00013
doi: 10.1097/00000658-199806000-00013 pubmed: 9637553 pmcid: 1191400
Shi Y, Peng C, Shen B, Deng X, Jin J, Wu Z, Zhan Q, Li H (2016) Pancreatic enucleation using the da Vinci robotic surgical system: a report of 26 cases. Int J Med Robot Comput Assist Surg. https://doi.org/10.1002/rcs.1719
doi: 10.1002/rcs.1719
Tanaka K, Misawa T, Haruki K, Saito R, Gocho T, Akiba T (2017) Enucleation of solid pseudopapillary tumor with a preoperative nasopancreatic drainage stent in a child. Asian J Endosc Surg. https://doi.org/10.1111/ases.12397
doi: 10.1111/ases.12397 pubmed: 28703507
De Bruijn KMJ, Van Eijck CHJ (2015) New-onset diabetes after distal pancreatectomy: a systematic review. Ann Surg. https://doi.org/10.1097/SLA.0000000000000819
doi: 10.1097/SLA.0000000000000819 pubmed: 26167723
Beger HG, Poch B, Mayer B, Siech M (2018) New onset of diabetes and pancreatic exocrine insufficiency after pancreaticoduodenectomy for benign and malignant tumors: a systematic review and meta-analysis of long-term results. Ann Surg. https://doi.org/10.1097/SLA.0000000000002422
doi: 10.1097/SLA.0000000000002422 pubmed: 28834847
Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P (2008) Pancreatic insufficiency after different resections for benign tumours. Br J Surg. https://doi.org/10.1002/bjs.5652
doi: 10.1002/bjs.5652 pubmed: 18041022
Jilesen APJ, Van Eijck CHJ, Busch ORC, Van Gulik TM, Gouma DJ, Van Dijkum EJMN (2016) Postoperative outcomes of enucleation and standard resections in patients with a pancreatic neuroendocrine tumor. World J Surg. https://doi.org/10.1007/s00268-015-3341-9
doi: 10.1007/s00268-015-3341-9 pubmed: 26661846
Crippa S, Zerbi A, Boninsegna L, Capitanio V, Partelli S, Balzano G, Pederzoli P, Di Carlo V, Falconi M (2012) Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Arch Surg. https://doi.org/10.1001/archsurg.2011.1843
doi: 10.1001/archsurg.2011.1843 pubmed: 22430908
Brient C, Regenet N, Sulpice L, Brunaud L, Mucci-Hennekine S, Carrère N, Milin J, Ayav A, Pradere B, Hamy A, Bresler L, Meunier B, Mirallié E (2012) Risk factors for postoperative pancreatic fistulization subsequent to enucleation. J Gastrointest Surg. https://doi.org/10.1007/s11605-012-1971-x
doi: 10.1007/s11605-012-1971-x pubmed: 22872510
Cherif R, Gaujoux S, Couvelard A, Dokmak S, Vuillerme MP, Ruszniewski P, Belghiti J, Sauvanet A (2012) Parenchyma-sparing resections for pancreatic neuroendocrine tumors. J Gastrointest Surg. https://doi.org/10.1007/s11605-012-2002-7
doi: 10.1007/s11605-012-2002-7 pubmed: 22911124
Heeger K, Falconi M, Partelli S, Waldmann J, Crippa S, Fendrich V, Bartsch DK (2014) Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors. Langenbeck’s Arch Surg. https://doi.org/10.1007/s00423-014-1171-0
doi: 10.1007/s00423-014-1171-0
Strobel O, Cherrez A, Hinz U, Mayer P, Kaiser J, Fritz S, Schneider L, Klauss M, Büchler MW, Hackert T (2015) Risk of pancreatic fistula after enucleation of pancreatic tumours. Br J Surg. https://doi.org/10.1002/bjs.9843
doi: 10.1002/bjs.9843 pubmed: 26109380
Wang X, Tan CL, Zhang H, Chen YH, Yang M, Ke NW, Liu XB (2018) Short-term outcomes and risk factors for pancreatic fistula after pancreatic enucleation: a single-center experience of 142 patients. J Surg Oncol. https://doi.org/10.1002/jso.24804
doi: 10.1002/jso.24804 pubmed: 30561818 pmcid: 6904950
Dalla Valle R, Cremaschi E, Lamecchi L, Guerini F, Rosso E, Iaria M (2019) Open and minimally invasive pancreatic neoplasms enucleation: a systematic review. Surg Endosc. https://doi.org/10.1007/s00464-019-06967-9
doi: 10.1007/s00464-019-06967-9 pubmed: 31363894
Afghani E, Akshintala VS, Khashab MA, Law JK, Hutfless SM, Kim KJ, Lennon AM, Kalloo AN, Singh VK (2014) 5-Fr vs 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis. Endoscopy. https://doi.org/10.1055/s-0034-1365701
doi: 10.1055/s-0034-1365701 pubmed: 24830399
Salvia R, Malleo G, Butturini G, Dal Molin M, Esposito A, Marchegiani G, Paiella S, Malpaga A, Fontana M, Personi B, Bassi C (2013) Perioperative management of patients undergoing pancreatic resection: implementation of a care plan in a tertiary-care center. J Surg Oncol. https://doi.org/10.1002/jso.23285
doi: 10.1002/jso.23285 pubmed: 23129003
Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo CJ, Büchler MW (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. https://doi.org/10.1016/j.surg.2007.05.005
doi: 10.1016/j.surg.2007.05.005 pubmed: 17981197
Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R, Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, Wolfgang CL, Yeo CJ, Salvia R, Buchler M (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery (US). https://doi.org/10.1016/j.surg.2016.11.014
doi: 10.1016/j.surg.2016.11.014
Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Yeo CJ, Büchler MW (2007) Postpancreatectomy hemorrhage (PPH)—an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. https://doi.org/10.1016/j.surg.2007.02.001
doi: 10.1016/j.surg.2007.02.001 pubmed: 17981197
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15570203 pmcid: 1356513
Lu WJ, Xu B, Gao SL, Dong X, Zhang B, Wu YL (2012) Enucleation of benign or borderline pancreatic head tumors adjacent to the common pancreatic duct. Pancreas. https://doi.org/10.1097/MPA.0b013e318229b891
doi: 10.1097/MPA.0b013e318229b891 pubmed: 22699142 pmcid: 3310302
Jin JB, Qin K, Li H, Wu ZC, Zhan Q, Deng XX, Chen H, Shen BY, Peng CH, Li HW (2016) Robotic enucleation for benign or borderline tumours of the pancreas: a retrospective analysis and comparison from a high-volume centre in Asia. World J Surg. https://doi.org/10.1007/s00268-016-3655-2
doi: 10.1007/s00268-016-3655-2 pubmed: 27491323
Shimura T, Suehiro T, Suzuki H, Mochida Y, Okada K, Araki K, Kuwano H (2007) Preoperative endoscopic pancreatic stenting for prophylaxis of pancreatic duct disruption during extirpation of a pancreatic head tumor. Am J Surg. https://doi.org/10.1016/j.amjsurg.2006.11.043
doi: 10.1016/j.amjsurg.2006.11.043 pubmed: 17826078
Song KB, Kim SC, Hwang DW, Lee JH, Lee DJ, Lee JW, Jun ES, Sin SH, Kim HE, Park KM, Lee YJ (2015) Enucleation for benign or low-grade malignant lesions of the pancreas: Single-center experience with 65 consecutive patients. Surgery (US). https://doi.org/10.1016/j.surg.2014.10.008
doi: 10.1016/j.surg.2014.10.008 pmcid: 4616853
Ide S, Uchida K, Inoue M, Koike Y, Otake K, Matsushita K, Hashimoto K, Nagano Y, Inoue H, Isaji S, Kusunoki M (2012) Tumor enucleation with preoperative endoscopic transpapillary stenting for pediatric insulinoma. Pediatr Surg Int. https://doi.org/10.1007/s00383-012-3104-8
doi: 10.1007/s00383-012-3104-8 pubmed: 22576843
Misawa T, Imazu H, Fujiwara Y, Kitamura H, Tsutsui N, Ito R, Shiba H, Futagawa Y, Wakiyama S, Ishida Y, Yanaga K (2013) Efficacy of nasopancreatic stenting prior to laparoscopic enucleation of pancreatic neuroendocrine tumor. Asian J Endosc Surg. https://doi.org/10.1111/ases.12006
doi: 10.1111/ases.12006 pubmed: 23879420
Kim S, Kim JW, Jung PY, Kwon HY, Shim H, Jang JY, Bae KS (2017) Diagnostic and therapeutic role of endoscopic retrograde pancreatography in the management of traumatic pancreatic duct injury patients: single center experience for 34 years. Int J Surg. https://doi.org/10.1016/j.ijsu.2017.03.054
doi: 10.1016/j.ijsu.2017.03.054 pubmed: 29198632
Krige JEJ, Kotze UK, Navsaria PH, Nicol AJ (2015) Endoscopic and operative treatment of delayed complications after pancreatic trauma: an analysis of 27 civilians treated in an academic Level 1 Trauma Centre. Pancreatology. https://doi.org/10.1016/j.pan.2015.06.008
doi: 10.1016/j.pan.2015.06.008 pubmed: 26212379
Buccimazza I, Thomson SR, Anderson F, Naidoo NM, Clarke DL (2006) Isolated main pancreatic duct injuries spectrum and management. Am J Surg. https://doi.org/10.1016/j.amjsurg.2005.11.015
doi: 10.1016/j.amjsurg.2005.11.015 pubmed: 16531134
Maire F, Ponsot P, Debove C, Dokmak S, Ruszniewski P, Sauvanet A (2015) Endoscopic management of pancreatic fistula after enucleation of pancreatic tumors. Surg Endosc. https://doi.org/10.1007/s00464-014-4034-4
doi: 10.1007/s00464-014-4034-4 pubmed: 25515987
Tryliskyy Y, Bryce GJ (2018) Post-ERCP pancreatitis: pathophysiology, early identification and risk stratification. Adv Clin Exp Med. https://doi.org/10.17219/acem/66773
doi: 10.17219/acem/66773 pubmed: 29521055
Neuhaus H (2004) Therapeutic pancreatic endoscopy. Endoscopy. https://doi.org/10.1055/s-2004-814119
doi: 10.1055/s-2004-814119 pubmed: 15326574
Dumonceau JM, Andriulli A, Elmunzer BJ, Mariani A, Meister T, Deviere J, Marek T, Baron TH, Hassan C, Testoni PA, Kapral C (2014) Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline—updated June 2014. Endoscopy. https://doi.org/10.1055/s-0034-1377875
doi: 10.1055/s-0034-1377875 pubmed: 25532114
Zolotarevsky E, Fehmi SM, Anderson MA, Schoenfeld PS, Elmunzer BJ, Kwon RS, Piraka CR, Wamsteker EJ, Scheiman JM, Korsnes SJ, Normolle DP, Kim HM, Elta GH (2011) Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial. Endoscopy. https://doi.org/10.1055/s-0030-1256305
doi: 10.1055/s-0030-1256305 pubmed: 21455872 pmcid: 3514442

Auteurs

Tommaso Giuliani (T)

Unit of General and Pancreatic Surgery, The Pancreas Institute, University of Verona, Verona Hospital Trust, P.le L.A. Scuro n° 10, 37134, Verona, Italy.

Giovanni Marchegiani (G)

Unit of General and Pancreatic Surgery, The Pancreas Institute, University of Verona, Verona Hospital Trust, P.le L.A. Scuro n° 10, 37134, Verona, Italy.

Mark D Girgis (MD)

Division of Surgical Oncology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.

Stefano Francesco Crinò (SF)

Unit of Gastroenterology and Digestive Endoscopy, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy.

Venkataraman R Muthusamy (VR)

Division of Digestive Diseases, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.

Laura Bernardoni (L)

Unit of Gastroenterology and Digestive Endoscopy, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy.

Antonio Pea (A)

Unit of General and Pancreatic Surgery, The Pancreas Institute, University of Verona, Verona Hospital Trust, P.le L.A. Scuro n° 10, 37134, Verona, Italy.

Marco Ramera (M)

Unit of General and Pancreatic Surgery, The Pancreas Institute, University of Verona, Verona Hospital Trust, P.le L.A. Scuro n° 10, 37134, Verona, Italy.

Salvatore Paiella (S)

Unit of General and Pancreatic Surgery, The Pancreas Institute, University of Verona, Verona Hospital Trust, P.le L.A. Scuro n° 10, 37134, Verona, Italy.

Luca Landoni (L)

Unit of General and Pancreatic Surgery, The Pancreas Institute, University of Verona, Verona Hospital Trust, P.le L.A. Scuro n° 10, 37134, Verona, Italy. Luca.landoni@aovr.veneto.it.

Armando Gabbrielli (A)

Unit of Gastroenterology and Digestive Endoscopy, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy.

Roberto Salvia (R)

Unit of General and Pancreatic Surgery, The Pancreas Institute, University of Verona, Verona Hospital Trust, P.le L.A. Scuro n° 10, 37134, Verona, Italy.

Timothy R Donahue (TR)

Division of Surgical Oncology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.

Claudio Bassi (C)

Unit of General and Pancreatic Surgery, The Pancreas Institute, University of Verona, Verona Hospital Trust, P.le L.A. Scuro n° 10, 37134, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH